These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24058299)

  • 1. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.
    Peeters S; Gilmore AB
    PLoS Med; 2013; 10(9):e1001506. PubMed ID: 24058299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How online sales and promotion of snus contravenes current European Union legislation.
    Peeters S; Gilmore AB
    Tob Control; 2013 Jul; 22(4):266-73. PubMed ID: 22267980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials.
    Gilmore AB
    Tob Control; 2012 Mar; 21(2):119-26. PubMed ID: 22345234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco industry manipulation of tobacco excise and tobacco advertising policies in the Czech Republic: an analysis of tobacco industry documents.
    Shirane R; Smith K; Ross H; Silver KE; Williams S; Gilmore A
    PLoS Med; 2012; 9(6):e1001248. PubMed ID: 22745606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in tobacco excise policy in Bulgaria: the role of tobacco industry lobbying and smuggling.
    Skafida V; Silver KE; Rechel BP; Gilmore AB
    Tob Control; 2014 May; 23(e1):e75-84. PubMed ID: 23143869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceuticalisation as the tobacco industry's endgame.
    Hendlin YH; Han EL; Ling PM
    BMJ Glob Health; 2024 Feb; 9(2):. PubMed ID: 38316465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation.
    Lee S; Lee K; Holden C
    Tob Control; 2014 May; 23(3):e8. PubMed ID: 23152099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to combat efforts to overturn bans on electronic nicotine delivery systems: lessons from tobacco industry efforts during the 1980s to open closed cigarette markets in Thailand.
    Patanavanich R; Glantz SA
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33500264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transnational Tobacco Companies and New Nicotine Delivery Systems.
    Mathers A; Hawkins B; Lee K
    Am J Public Health; 2019 Feb; 109(2):227-235. PubMed ID: 30571303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'A major lobbying effort to change and unify the excise structure in six Central American countries': How British American Tobacco influenced tax and tariff rates in the Central American Common Market.
    Holden C; Lee K
    Global Health; 2011 May; 7():15. PubMed ID: 21595921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing smokeless tobacco products for smokers: an examination of tobacco industry documents.
    Carpenter CM; Connolly GN; Ayo-Yusuf OA; Wayne GF
    Tob Control; 2009 Feb; 18(1):54-9. PubMed ID: 18948390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Working the system"--British American tobacco's influence on the European union treaty and its implications for policy: an analysis of internal tobacco industry documents.
    Smith KE; Fooks G; Collin J; Weishaar H; Mandal S; Gilmore AB
    PLoS Med; 2010 Jan; 7(1):e1000202. PubMed ID: 20084098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining Market Trends in Smokeless Tobacco Sales in the United States: 2011-2019.
    Delnevo CD; Hrywna M; Miller Lo EJ; Wackowski OA
    Nicotine Tob Res; 2021 Aug; 23(8):1420-1424. PubMed ID: 33241271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining market trends in the United States smokeless tobacco use: 2005-2011.
    Delnevo CD; Wackowski OA; Giovenco DP; Manderski MT; Hrywna M; Ling PM
    Tob Control; 2014 Mar; 23(2):107-12. PubMed ID: 23117999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global health governance and the commercial sector: a documentary analysis of tobacco company strategies to influence the WHO framework convention on tobacco control.
    Weishaar H; Collin J; Smith K; Grüning T; Mandal S; Gilmore A
    PLoS Med; 2012; 9(6):e1001249. PubMed ID: 22745607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of "American Snus" and Swedish Snus Products for Sale in Massachusetts, USA.
    Seidenberg AB; Ayo-Yusuf OA; Rees VW
    Nicotine Tob Res; 2018 Jan; 20(2):262-266. PubMed ID: 28003512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society-An Observational Study over a 16 Year Period.
    Lund KE; Vedoy TF
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30862006
    [No Abstract]   [Full Text] [Related]  

  • 19. Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union-part I: establishing cigarette imports.
    Gilmore AB; McKee M
    Tob Control; 2004 Jun; 13(2):143-50. PubMed ID: 15175531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.